IRIS Accounts Production v25.1.3.33 10535886 Board of Directors Board of Directors Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh105358862023-12-31105358862024-12-31105358862024-01-012024-12-31105358862022-12-31105358862023-01-012023-12-31105358862023-12-3110535886ns15:EnglandWales2024-01-012024-12-3110535886ns14:PoundSterling2024-01-012024-12-3110535886ns10:Director12024-01-012024-12-3110535886ns10:Director22024-01-012024-12-3110535886ns10:Director32024-01-012024-12-3110535886ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110535886ns10:SmallEntities2024-01-012024-12-3110535886ns10:AuditExemptWithAccountantsReport2024-01-012024-12-3110535886ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110535886ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110535886ns10:FullAccounts2024-01-012024-12-3110535886ns10:RegisteredOffice2024-01-012024-12-3110535886ns5:CurrentFinancialInstruments2024-12-3110535886ns5:CurrentFinancialInstruments2023-12-3110535886ns5:Non-currentFinancialInstruments2024-12-3110535886ns5:Non-currentFinancialInstruments2023-12-3110535886ns5:ShareCapital2024-12-3110535886ns5:ShareCapital2023-12-3110535886ns5:RetainedEarningsAccumulatedLosses2024-12-3110535886ns5:RetainedEarningsAccumulatedLosses2023-12-3110535886ns5:FurnitureFittings2023-12-3110535886ns5:ComputerEquipment2023-12-3110535886ns5:FurnitureFittings2024-01-012024-12-3110535886ns5:ComputerEquipment2024-01-012024-12-3110535886ns5:FurnitureFittings2024-12-3110535886ns5:ComputerEquipment2024-12-3110535886ns5:FurnitureFittings2023-12-3110535886ns5:ComputerEquipment2023-12-3110535886ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-12-3110535886ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-31
REGISTERED NUMBER: 10535886 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2024

for

Vetro Health Limited

Vetro Health Limited (Registered number: 10535886)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Certified Accountants' Report 6

Vetro Health Limited

Company Information
for the Year Ended 31 December 2024







DIRECTORS: V A Davies
A J Tulloch
T J Cox





REGISTERED OFFICE: Declare Court
Units 5 and 6 Pontygwindy Ind Estate
Caerphilly
Wales
CF83 3HU





REGISTERED NUMBER: 10535886 (England and Wales)





ACCOUNTANTS: Ascott Blake Ltd
11 Ducketts Wharf
Bishop's Stortford
Hertfordshire
CM23 3AR

Vetro Health Limited (Registered number: 10535886)

Balance Sheet
31 December 2024

31/12/24 31/12/23
Notes £    £   
FIXED ASSETS
Tangible assets 4 57 355

CURRENT ASSETS
Debtors 5 118,613 143,272
Cash at bank 33,697 95,980
152,310 239,252
CREDITORS
Amounts falling due within one year 6 (63,132 ) (62,341 )
NET CURRENT ASSETS 89,178 176,911
TOTAL ASSETS LESS CURRENT
LIABILITIES

89,235

177,266

CREDITORS
Amounts falling due after more than one year 7 (12,422 ) (24,167 )
NET ASSETS 76,813 153,099

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 76,713 152,999
76,813 153,099

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Vetro Health Limited (Registered number: 10535886)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 September 2025 and were signed on its behalf by:




A J Tulloch - Director V A Davies - Director




T J Cox - Director


Vetro Health Limited (Registered number: 10535886)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Vetro Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings - 25% on reducing balance
Computer equipment - 33% straight line method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 42 (2023 - 42 ) .

Vetro Health Limited (Registered number: 10535886)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

4. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 January 2024
and 31 December 2024 320 977 1,297
DEPRECIATION
At 1 January 2024 244 698 942
Charge for year 19 279 298
At 31 December 2024 263 977 1,240
NET BOOK VALUE
At 31 December 2024 57 - 57
At 31 December 2023 76 279 355

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/24 31/12/23
£    £   
Trade debtors 100,115 92,256
Amounts owed by participating interests 18,498 29,188
Other debtors - 21,828
118,613 143,272

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/12/24 31/12/23
£    £   
Bank loans and overdrafts 16,389 -
Trade creditors 2,843 26,246
Tax 753 19,230
Social security and other taxes 22,708 4,416
Pensions account 645 921
Accruals and deferred income 19,794 11,528
63,132 62,341

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31/12/24 31/12/23
£    £   
Bounce back loan 12,422 24,167

Chartered Certified Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Vetro Health Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Vetro Health Limited for the year ended 31 December 2024 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/rulebook.

This report is made solely to the Board of Directors of Vetro Health Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Vetro Health Limited and state those matters that we have agreed to state to the Board of Directors of Vetro Health Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at
https://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/tf-163-jan-24.pdf.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Vetro Health Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Vetro Health Limited. You consider that Vetro Health Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Vetro Health Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Ascott Blake Ltd
11 Ducketts Wharf
Bishop's Stortford
Hertfordshire
CM23 3AR


8 September 2025